Marshall Wace North America’s Sabra Healthcare REIT SBRA Stock Holding History

Marshall Wace North America’s Portfolio SBRA Stock Details SBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-60,914	Closed	-$1.11M	–	1678
2021 Q2	$1.11M	Sell	60,914 -73,987	-55%	-$1.32M	﹤0.01%	984
2021 Q1	$2.34M	Sell	134,901 -6,844	-5%	-$120K	0.01%	777
2020 Q4	$2.46M	Buy	141,745 +35,487	+33%	+$566K	0.01%	701
2020 Q3	$1.47M	Sell	106,258 -60,071	-36%	-$882K	0.01%	690
2020 Q2	$2.4M	Buy	+166,329	New	+$2.19M	0.02%	535
2020 Q1	–	Sell	-605,318	Closed	-$12.9M	–	1553
2019 Q4	$12.9M	Buy	+605,318	New	+$13.6M	0.06%	254
2019 Q3	–	Sell	-17,303	Closed	-$341K	–	1519
2019 Q2	$341K	Buy	+17,303	New	+$337K	﹤0.01%	955
2019 Q1	–	Sell	-75,005	Closed	-$1.24M	–	1863
2018 Q4	$1.24M	Buy	+75,005	New	+$1.51M	0.01%	560
2017 Q4	–	Sell	-384,998	Closed	-$8.47M	–	1583
2017 Q3	$8.47M	Buy	384,998 +329,692	+596%	+$7.45M	0.05%	416
2017 Q2	$1.33M	Buy	+55,306	New	+$1.41M	0.01%	847

Other funds holding SBRA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

AAMU

APG Asset Management US New York $14.3B AUM 16.79% 1-Year Est. Return

CIM

Centersquare Investment Management Conshohocken, Pennsylvania $11.7B AUM 20.39% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Marshall Wace North America's SBRA Position: Q3 2021 in Review

Marshall Wace North America sold out of Sabra Healthcare REIT (SBRA) in Q3 2021, closing a stake of 60,914 shares — an estimated $1.11M sold.

Marshall Wace North America first reported a position in SBRA in Q2 2017 and held it in 10 quarters. The position peaked at $12.9M in Q4 2019. 326 funds tracked by Wall St. Rank hold SBRA as of Q3 2021.

Marshall Wace North America reported no remaining Sabra Healthcare REIT position as of Q3 2021 after selling out during the quarter.
Marshall Wace North America sold 60,914 Sabra Healthcare REIT shares in Q3 2021, an estimated $1.11M.
Marshall Wace North America first reported a position in Sabra Healthcare REIT in Q2 2017 and held it in 10 quarters.
Marshall Wace North America's Sabra Healthcare REIT position peaked at $12.9M in Q4 2019.
326 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.